Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Vitamin D and multiple sclerosis: where do we go from here?
Longitudinal study of alexithymia and multiple sclerosis.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
France Banned AB Science Drug Studies Because of Side Effects
The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
MYRAC Rx
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Multiple sclerosis and the spinal cord.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
Neuromodulation of lower limb motor control in restorative neurology.
Managing MS: Trends, Issues, and Perspectives.

Pages